Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Duarte

Showing results (771-780 of 824) with videos related to

Pageof 83
Sort By:
Cytokine|August 25, 2018
A Leishmania hypothetical protein-containing liposome-based formulation is highly immunogenic and induces protection against visceral leishmaniasisPatrícia A F Ribeiro, Daniel S Dias, Marcus V M Novais, et al.
International Journal of Nanomedicine|November 28, 2014
An optimized nanoparticle delivery system based on chitosan and chondroitin sulfate molecules reduces the toxicity of amphotericin B and is effective in treating tegumentary leishmaniasisTatiana G Ribeiro, Juçara R Franca, Leonardo L Fuscaldi, et al.
Journal of Immunological Methods|August 11, 2019
Immunodiagnosis of human and canine visceral leishmaniasis using recombinant Leishmania infantum Prohibitin protein and a synthetic peptide containing its conformational B-cell epitopeMarcella R Rodrigues, Lucas M O Santos, Carolina K Miyazaki, et al.
Parasitology|November 9, 2017
Antigenicity, immunogenicity and protective efficacy of a conserved Leishmania hypothetical protein against visceral leishmaniasisDaniel S Dias, Vívian T Martins, Patrícia A F Ribeiro, et al.
Inflammopharmacology|July 11, 2020
Reduced cutaneous inflammation associated with antioxidant action after topical application of the aqueous extract of Annona muricata leavesLuana M Cercato, Jéssica M D Araújo, Alan S Oliveira, et al.
Clinical and Vaccine Immunology : CVI|September 18, 2015
Proteins Selected in Leishmania (Viannia) braziliensis by an Immunoproteomic Approach with Potential Serodiagnosis Applications for Tegumentary LeishmaniasisMariana C Duarte, Daniel C Pimenta, Daniel Menezes-Souza, et al.
Lupus|October 17, 2014
Characterization of damage in Portuguese lupus patients: analysis of a national lupus registryM J Gonçalves, S Sousa, L S Inês, et al.
Clinical and Vaccine Immunology : CVI|November 22, 2013
Subtractive phage display selection from canine visceral leishmaniasis identifies novel epitopes that mimic Leishmania infantum antigens with potential serodiagnosis applicationsLourena E Costa, Mayara I S Lima, Miguel A Chávez-Fumagalli, et al.
Parasitology|April 21, 2020
An immunoproteomics approach to identify <i>Leishmania infantum</i> proteins to be applied for the diagnosis of visceral leishmaniasis and human immunodeficiency virus co-infectionAmanda S Machado, Fernanda F Ramos, João A Oliveira-da-Silva, et al.
Clinical and Vaccine Immunology : CVI|April 5, 2013
Sensitive and specific serodiagnosis of Leishmania infantum infection in dogs by using peptides selected from hypothetical proteins identified by an immunoproteomic approachMiguel A Chávez-Fumagalli, Vivian T Martins, Miriam C S Testasicca, et al.
Pageof 83

Showing results (771-780 of 824) with videos related to

Sort By:
Pageof 83
Cytokine|August 25, 2018
A Leishmania hypothetical protein-containing liposome-based formulation is highly immunogenic and induces protection against visceral leishmaniasisPatrícia A F Ribeiro, Daniel S Dias, Marcus V M Novais, et al.
International Journal of Nanomedicine|November 28, 2014
An optimized nanoparticle delivery system based on chitosan and chondroitin sulfate molecules reduces the toxicity of amphotericin B and is effective in treating tegumentary leishmaniasisTatiana G Ribeiro, Juçara R Franca, Leonardo L Fuscaldi, et al.
Journal of Immunological Methods|August 11, 2019
Immunodiagnosis of human and canine visceral leishmaniasis using recombinant Leishmania infantum Prohibitin protein and a synthetic peptide containing its conformational B-cell epitopeMarcella R Rodrigues, Lucas M O Santos, Carolina K Miyazaki, et al.
Parasitology|November 9, 2017
Antigenicity, immunogenicity and protective efficacy of a conserved Leishmania hypothetical protein against visceral leishmaniasisDaniel S Dias, Vívian T Martins, Patrícia A F Ribeiro, et al.
Inflammopharmacology|July 11, 2020
Reduced cutaneous inflammation associated with antioxidant action after topical application of the aqueous extract of Annona muricata leavesLuana M Cercato, Jéssica M D Araújo, Alan S Oliveira, et al.
Clinical and Vaccine Immunology : CVI|September 18, 2015
Proteins Selected in Leishmania (Viannia) braziliensis by an Immunoproteomic Approach with Potential Serodiagnosis Applications for Tegumentary LeishmaniasisMariana C Duarte, Daniel C Pimenta, Daniel Menezes-Souza, et al.
Lupus|October 17, 2014
Characterization of damage in Portuguese lupus patients: analysis of a national lupus registryM J Gonçalves, S Sousa, L S Inês, et al.
Clinical and Vaccine Immunology : CVI|November 22, 2013
Subtractive phage display selection from canine visceral leishmaniasis identifies novel epitopes that mimic Leishmania infantum antigens with potential serodiagnosis applicationsLourena E Costa, Mayara I S Lima, Miguel A Chávez-Fumagalli, et al.
Parasitology|April 21, 2020
An immunoproteomics approach to identify <i>Leishmania infantum</i> proteins to be applied for the diagnosis of visceral leishmaniasis and human immunodeficiency virus co-infectionAmanda S Machado, Fernanda F Ramos, João A Oliveira-da-Silva, et al.
Clinical and Vaccine Immunology : CVI|April 5, 2013
Sensitive and specific serodiagnosis of Leishmania infantum infection in dogs by using peptides selected from hypothetical proteins identified by an immunoproteomic approachMiguel A Chávez-Fumagalli, Vivian T Martins, Miriam C S Testasicca, et al.
Pageof 83